According to Figure 3, the significant predictive effect of DAPT duration on composite bleeding events was primarily reflected in the subgroups of patients aged < 70 years and patients aged ≥70 years, patients who were men, patients with a history of hypertension, patients with and without a history of DM, patients who experienced ischemic stroke, and patients with a history of PAD, Hb ≥120 g/L and <120 g/L, LVEF <50%, eGFR <60 ml/min/1.73 m2 and ≥60 ml/min/1.73 m2, BMI <25 kg/m2, HbA1c <6.5% and ≥6.5%, SBP ≥120 mmHg and <120 mmHg, and heart rate ≥80 bpm and <80 bpm. The gene discussed is GSTM1; the disease is ischemic stroke.